Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Adlego Biomedical AB
AB
Dissolved
Org 5566814116
Research and experimental development on biotechnology
·
NACE 7211
Est. 2005 · 21 years old
12 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
Adlego Biomedical AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PS
Pontus Stefan Axel Ohlsson
Chief Auditor
Chief Auditor
2022
BJ
Björn Johan Georg Platzack
Chief Executive Officer
Chief Executive Officer
2022
Former (2)
EO
Erik Oskar Wall
Chief Auditor
Chief Auditor
2022 – 2024
MC
Malin Christina Evesäter
Audit
Audit
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JL
Jeanet Løgsted Nielsen
Board of Directors
Board of Directors
2022
MA
Martin Amtoft-Christensen
Deputy Board Member
Deputy Board Member
2022
Former (2)
JE
Jonas Erik Anders Höglund
Deputy Board Member
Deputy Board Member
2022 – 2022
AU
Anders Urban Höglund
Board of Directors
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Adlego Biomedical AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network